# Metabolic Imaging of the Heart Using Hyperpolarized (13C) Pyruvate Injection

> **NCT02648009** · PHASE1 · RECRUITING · sponsor: **Sunnybrook Health Sciences Centre** · enrollment: 112 (estimated)

## Conditions studied

- Hypertension
- Hypertrophy

## Interventions

- **DRUG:** Hyperpolarized (13) Pyruvate Injection
- **DRUG:** Gadolinium

## Key facts

- **NCT ID:** NCT02648009
- **Lead sponsor:** Sunnybrook Health Sciences Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2016-04
- **Primary completion:** 2027-04
- **Final completion:** 2027-04
- **Target enrollment:** 112 (ESTIMATED)
- **Last updated:** 2026-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02648009

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02648009, "Metabolic Imaging of the Heart Using Hyperpolarized (13C) Pyruvate Injection". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02648009. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*